Prevalence and disease association of TT virus infection in Japanese patients with viral hepatitis

Hepatology Research

Volumn 14, Issue 2, 1999, Pages 161-170

  Orii, Koji ^a   Tanaka, Eiji ^a   Umemura, Takeji ^a   Rokuhara, Akinori ^a   Iijima, Akihiro ^a   Yoshizawa, Kaname ^a   Imai, Haruhiko ^a   Kiyosawa, Kendo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dual infection; Non A E hepatitis; PCR; TT virus

Indexed keywords

ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS NON A NON B; HUMAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS HEPATITIS; VIRUS PATHOGENESIS;

EID: 0032927427     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1386-6346(98)00122-3     Document Type: Article

References (19)

1. Alter H.J., Purcell R.H., Shih J.W. et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. New Engl J Med. 321:1989;1494-1500.
2. Aach R.D., Stevens C.E., Hollinger F.B. et al. Hepatitis C virus infection in post-transfusion hepatitis. New Engl J Med. 325:1991;1325-1329.
3. Alter M.J., Margolis H.S., Krawczynski K. et al. The natural history of community-acquired hepatitis C in the United States. New Engl J Med. 325:1991;1324-1329.
4. Feray C., Gigou M., Samuel D. et al. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology. 104:1993;549-555.
5. Wright T.L. Etiology of fulminant hepatic failure: is another virus involved? Gastroenterology. 104:1993;640-643.
6. Simonds J.N., Leary T.P., Drawson G.J. et al. Isolation of novel virus-like sequence associated with human hepatitis. Nat Med. 1:1995;564-569.
7. Linnen J., Wages J., Zhang-Keck Z.Y. et al. Molecular cloning and disease association of hepatitis G virus: a new transfusion transmissible agent. Science. 271:1996;505-508.
8. Tanaka E., Alter H.J., Nakatsuji Y. et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med. 125:1996;740-743.
9. Masuko K., Mitsui T., Iwano K. et al. High prevalence of GB virus C in patients on maintenance hemodialysis. New Engl J Med. 334:1996;1485-1490.
10. Nishizawa T., Okamoto H., Konishi K., Yoshizawa H., Miyakawa Y., Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in post-transfusion hepatitis of unknown etiology. Biochem Biophys Res Commun. 241:1997;92-97.
11. Okamoto H., Nishizawa T., Kato N., Ukita M., Ikeda H., Ishida H. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res. 10:1998;1-16.
12. Johnson P.J., McFarlane I.G. Convenors, on behalf of the panel. Meeting report: International autoimmune hepatitis group. Hepatology. 18:1993;998-1005.
13. Kaplan M.M. Primary biliary cirrhosis. New Engl J Med. 316:1987;521-528.
14. Miyakawa Y., Mayumi M. Hepatitis G virus-A true hepatitis virus or an accidental tourist? New Engl J Med. 336:1997;786-787.
15. Mishiro S., Hayashi S., Tanaka N. et al. Decrease in the zinc turbidity test values in patients with liver cirrhosis: a possible indicator for impending hepatocellular carcinoma. J Med. 14:1983;185-192.
16. Naoumov N.V., Petrova E.P., Thomas M.G., Williams R. Presence of a newly described human DNA virus (TTV) in patients with liver disease. Lancet. 352:1998;195-197.
17. Aikawa T., Sugai Y., Okmoto H. Hepatitis G infection in drug abusers with chronic hepatitis C [letter]. New Engl J Med. 334:1996;165-196.
18. Alter H.J., Nakatsuji Y., Melpolder J. et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. New Engl J Med. 336:1997;747-754.
19. Tanaka E., Tacke M., Kobayashi M. et al. Past and present hepatitis G virus infections in areas where hepatitis C is highly endemic and those where it is not endemic. J Clin Microbiol. 36:1998;110-114.